These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10999492)

  • 1. Hormone replacement therapy should not be used as secondary prevention of coronary heart disease.
    Barbour MM
    Pharmacotherapy; 2000 Sep; 20(9):1021-7. PubMed ID: 10999492
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormone replacement therapy should be administered as secondary prevention of coronary artery disease.
    Spencer AP
    Pharmacotherapy; 2000 Sep; 20(9):1028-33. PubMed ID: 10999493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What pharmacists need to know about the women's health initiative estrogen plus progestin trial.
    Saseen JJ; Hansen LB
    Am J Health Syst Pharm; 2003 Feb; 60(3):281-4. PubMed ID: 12613239
    [No Abstract]   [Full Text] [Related]  

  • 4. Hormone replacement therapy and heart disease prevention: experimentation trumps observation.
    Petitti DB
    JAMA; 1998 Aug; 280(7):650-2. PubMed ID: 9718060
    [No Abstract]   [Full Text] [Related]  

  • 5. Hormone replacement therapy to prevent coronary events.
    Richard D; Newton WP
    J Fam Pract; 1998 Nov; 47(5):333-4. PubMed ID: 9834761
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharma-clinics. Drug of the month. Premelle (conjugated estrogens + medroxyprogesterone].
    Scheen AJ
    Rev Med Liege; 1998 Oct; 53(10):638-40. PubMed ID: 9857760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of estrogen plus progestin therapy for prevention.
    Fletcher SW; Colditz GA
    JAMA; 2002 Jul; 288(3):366-8. PubMed ID: 12117403
    [No Abstract]   [Full Text] [Related]  

  • 8. Commentary on "menopausal hormone treatment in postmenopausal women: risks and benefits".
    Archer DF
    South Med J; 2014 Nov; 107(11):696-7. PubMed ID: 25365436
    [No Abstract]   [Full Text] [Related]  

  • 9. Estrogen therapy for unstable angina: another bump for the bandwagon.
    Waters DD
    J Am Coll Cardiol; 2002 Jan; 39(2):238-40. PubMed ID: 11788213
    [No Abstract]   [Full Text] [Related]  

  • 10. The heart and estrogen/progestin replacement study (HERS).
    Speroff L
    Maturitas; 1998 Nov; 31(1):9-14. PubMed ID: 10091199
    [No Abstract]   [Full Text] [Related]  

  • 11. Estrogen replacement therapy: new options, continuing concerns.
    Hanson RM; Melzer DJ
    JAMA; 1997 May; 277(19):1515; author reply 1515-7. PubMed ID: 9153359
    [No Abstract]   [Full Text] [Related]  

  • 12. Does estrogen/progestin therapy in post-menopausal women decrease their risk of fracture?
    Groh KW; Stevermer JJ
    J Fam Pract; 2001 Nov; 50(11):926. PubMed ID: 11711004
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
    Grady D; Herrington D; Bittner V; Blumenthal R; Davidson M; Hlatky M; Hsia J; Hulley S; Herd A; Khan S; Newby LK; Waters D; Vittinghoff E; Wenger N;
    JAMA; 2002 Jul; 288(1):49-57. PubMed ID: 12090862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are less than standard doses of hormone replacement therapy (HRT) effective for the treatment of hot flushes?
    Andy C
    J Fam Pract; 2001 Sep; 50(9):743. PubMed ID: 11674902
    [No Abstract]   [Full Text] [Related]  

  • 15. HRT: forever or never?
    Corson SL
    Int J Fertil Womens Med; 2002; 47(4):150-1. PubMed ID: 12199410
    [No Abstract]   [Full Text] [Related]  

  • 16. Consortium for the Assessment of Research on Progestins and Estrogens (CARPE) Fort Worth, Texas August 1-3, 2003.
    Simpkins JW; Singh M
    J Womens Health (Larchmt); 2004 Dec; 13(10):1165-8. PubMed ID: 15650349
    [No Abstract]   [Full Text] [Related]  

  • 17. Coronary heart disease in women, randomized clinical trials, HERS and RUTH.
    Barrett-Connor E; Wenger NK; Grady D; Mosca L; Collins P; Kornitzer M; Cox DA; Moscarelli E; Anderson PW
    Maturitas; 1998 Nov; 31(1):1-7. PubMed ID: 10091198
    [No Abstract]   [Full Text] [Related]  

  • 18. Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease.
    Herrington DM; Werbel BL; Riley WA; Pusser BE; Morgan TM
    J Am Coll Cardiol; 1999 Jun; 33(7):2030-7. PubMed ID: 10362210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy for prevention of coronary heart disease: current evidence.
    Khurana PS; Khurana C; Hsia J
    Curr Atheroscler Rep; 2001 Sep; 3(5):399-403. PubMed ID: 11487451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of unrecognized myocardial infarction in women with coronary heart disease.
    Shlipak MG; Elmouchi DA; Herrington DM; Lin F; Grady D; Hlatky MA;
    Ann Intern Med; 2001 Jun; 134(11):1043-7. PubMed ID: 11388817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.